Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer
Fenn, Kathleen, Maurer, Matthew, Lee, Shing M., Crew, Katherine D., Trivedi, Meghna S., Accordino, Melissa K., Hershman, Dawn L., Kalinsky, KevinLanguage:
english
Journal:
Clinical Breast Cancer
DOI:
10.1016/j.clbc.2019.08.004
Date:
August, 2019
File:
PDF, 346 KB
english, 2019